Patents for C12R 1 - Micro-organisms (92,025) |
---|
08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
08/07/2001 | US6270768 Azithromycins |
08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |
08/07/2001 | CA2080781C Method for the culture of microorganisms of the genera helicobacter, campylobacter and arcobacter employing culture media comprising cyclodextrins, methylcellulose or mixtures thereof |
08/07/2001 | CA2044746C Polypeptide compound and a process for preparation thereof |
08/02/2001 | WO2001055396A1 NOVEL POLYPEPTIDES HmrA AND HmrB |
08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
08/02/2001 | WO2001055297A2 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
08/02/2001 | WO2001055103A2 Chimeric neuropeptide y receptors |
08/02/2001 | WO2001054672A2 Closure of bacterial ghosts |
08/02/2001 | WO2001054510A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
08/02/2001 | WO2001016303A3 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
08/02/2001 | WO2001011053A3 Soluble, active recombinant human mao-b |
08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
08/02/2001 | WO2000065070A9 Cell culture process for glycoproteins |
08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
08/02/2001 | US20010011378 Isotype of starch synthase |
08/02/2001 | US20010011130 Materials and methods for detection of oxalate |
08/02/2001 | US20010011124 Genetic engineering |
08/02/2001 | US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin |
08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
08/02/2001 | US20010010912 nrdF |
08/02/2001 | US20010010900 Transducing phages |
08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
08/02/2001 | CA2786722A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
08/02/2001 | CA2760879A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
08/02/2001 | CA2423122A1 Closure of bacterial ghosts |
08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
08/02/2001 | CA2398084A1 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |
08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
08/01/2001 | EP1120465A1 D-Aminoacylase and gene encoding the same |
08/01/2001 | EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation |
08/01/2001 | EP1119629A2 Oxidoreductase molecules |
08/01/2001 | EP1119628A2 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
08/01/2001 | EP0698106B1 Marker gene |
08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
08/01/2001 | EP0654532B1 Antimucoglycoprotein monoclonal antibody |
08/01/2001 | EP0643135B1 Dna encoding aspartokinase iii mutants and their use for the production of l-threonine by fermentation |
08/01/2001 | EP0590012B1 Mutant proteolytic enzymes from bacillus |
08/01/2001 | CN1306581A Method for producing water-insoluble & alpha-1,4-glucan |
08/01/2001 | CN1306580A Mumbaistatin, process for its prodn. and its use as pharmaceutical |
08/01/2001 | CN1306577A Multiply-substituted protease variants |
08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
08/01/2001 | CN1306437A Vaccine |
08/01/2001 | CN1306400A Drinks and foods capable of eliminating helicobacter pylori |
08/01/2001 | CN1306007A Dry cell factor |
08/01/2001 | CA2330023A1 Levodione reductase gene and use thereof |
07/31/2001 | US6268549 DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
07/31/2001 | US6268492 Lysing cells, precipitating chromosomal dna and cell wall components to form flocculent solution, applying to depth filter to capture precipitate and allow non-chromosomal dna to pass through filter; not centrifuged before filtration |
07/31/2001 | US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography |
07/31/2001 | US6268485 Down-regulation resistant C3 convertase |
07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
07/31/2001 | US6268471 Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
07/31/2001 | US6268328 Variant EGIII-like cellulase compositions |
07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
07/31/2001 | US6268196 Contacting fabric containing cellulose with a treating agent consisting of a truncated cellulase lacking a cellulase binding domain, incubating fabric with cellulase; improving the feel of fabric and giving the fabric a stonewash look |
07/31/2001 | US6268195 A genetically engineered plant pectin methyl esterase enyzme; used in the food industry as a thickening or gelling agent, such as in the preparation of jams. |
07/31/2001 | US6268188 Transaminases and aminotransferases |
07/31/2001 | US6268185 Production of amino acids and enzymes used therefor |
07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
07/31/2001 | US6268178 Phage-dependent super-production of biologically active protein and peptides |
07/31/2001 | US6268171 Recombinant PilC proteins, methods for producing them and their use |
07/31/2001 | US6268169 Nucleic acids sequences encoding synthetic dragline variant protein; production of fabrics that are both light-weight and flexible without compromising strength and durability |
07/31/2001 | US6268127 Extracting nucleotide sequences from fluid sample; incubate fluid sample with alkali, heat fluid, centrifuge fluid, recover supernatant containing nucleotide sequences |
07/31/2001 | CA2276548C Improved methods for the preparation of endotoxin-binding proteins |
07/31/2001 | CA2129661C Biochemical purification of simvastatin |
07/31/2001 | CA2121144C Oligonucleotides having chiral phosphorus linkages |
07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
07/31/2001 | CA2079877C Bacillus thuringiensis strains and their genes encoding insecticidal toxins |
07/31/2001 | CA2069428C A mammalian cytokine, il-11 |
07/31/2001 | CA2033658C Glucose isomerases with an altered ph optimum |
07/26/2001 | WO2001053532A2 Barcoded synthetic lethal screening to identify drug targets |
07/26/2001 | WO2001053525A2 Cell isolation method |
07/26/2001 | WO2001053512A1 Solventless extraction process |
07/26/2001 | WO2001053474A2 Flavobacterium heparinum expression system |
07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
07/26/2001 | WO2001002583A3 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
07/26/2001 | WO2000045176A3 METHOD OF IDENTIFYING N-TERMINAL proBNP |
07/26/2001 | US20010009768 Polynucleotides encoding cytokine designated LERK-5 |
07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
07/26/2001 | CA2772540A1 Solventless extraction process |
07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
07/26/2001 | CA2398690A1 Barcoded synthetic lethal screening to identify drug targets |
07/26/2001 | CA2397562A1 Flavobacterium heparinum expression system |
07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |